HCW Biologics Inc is trading at $1.33 (8.3% down) in after-hours trading as the stock continues to face pressure from broader small-cap biotech volatility and risk-off sentiment.
- The move follows a sharp 10.7% decline during the regular session to $1.45, extending the stock's recent downside momentum.
- With no new company-specific filings or press releases reported, the underperformance appears tied to sector-wide liquidity pressures.
- HCW Biologics Inc is trailing broader markets, which remained roughly flat to slightly higher despite the volatility in the small-cap biotech space.